This case describes the reorganization of drug discovery at GlaxoSmithKline (GSK) following the formation of GSK from the merger of Glaxo Wellcome and SmithKline Beecham. This reorganization placed nearly 2‚000 research scientists into six centers of excellence in drug discovery (CEDD). Each CEDD focused on a small set of therapeutic areas and possessed decision rights over the progression of pharmaceutical compounds through the early stages of development. It addresses issues about the benefits
Premium Clinical trial Drug discovery Pharmaceutical industry
GlaxoSmithKline and AIDS Drugs for Africa What comes to mind when you hear the words “pharmaceutical company”? There are many ways to define a pharmaceutical company. According to the Princeton review‚ a pharmaceutical company is a drug company that makes and sells pharmaceuticals. Another definition for a pharmaceutical company is an industry that develops‚ produces‚ and markets drugs licensed for use as generic and/or brand medications. These companies are subject to a variety of laws and
Premium HIV Immune system AIDS
GlaxoSmithKline company profile Francis Weyzig Amsterdam‚ October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers‚ develops‚ manufactures and markets branded human health products. Headquarters: UK‚ with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA‚ France‚ Germany‚ UK‚ Italy and Japan Employees: approximately 103‚000 GSK key figures
Premium Pharmaceutical industry
GlaxoSmithKline 1. Who are the stakeholders in this case? Which are primary‚ and which are secondary? What influence do they have? Stakeholders for GlaxoSmithKline include the following: Employees; stockholders; creditors; suppliers; customers (both prescribing physicians and end users); retailers (domestically and internationally); activist groups (such as the Minnesota Senior Federation‚ the National Association of the Terminally Ill‚ the Coalition for Access to Affordable Prescription
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
KPIs for Drug Discovery STRATEGIC IMPERATIVES • • Product Quality Benchmarking among the competitors CRITICAL SUCCESS FACTORS • • • Sustainable quality High Standards Optimal Pricing Strategy KEY PERFORMANCE INDICATORS • • • • • Pioneers in Quality and Standards • • Positive results of Quality
Premium Customer service Customer
Chapter 1 Introduction To GlaxoSmithKline 1. INTRODUCTION: 1.1 COMPANY LOGO Image 1 GlaxoSmithKline is a leading‚ global‚ research-based healthcare and pharmaceutical company. In India‚ it is the number one pharmaceutical company. GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical‚ biologics‚ vaccines and consumer healthcare company headquartered in Brentford‚ London
Premium Pharmaceutical industry Pharmacology Generic drug
Glaxo Smith Kline Panoxyl Date Submitted November‚ 9‚ 2012 Prepared By Colin Williams BUS 360 SECTION 001 Table of Contents company offering product/SERVICE 1 Company Description 1 Company Location(s) 1 Other Products Offered 1 Market Areas Sells To 1 product/SERVICE being marketed 2 Description of Product 2 Features and Capabilities 2 Product Life Cycle 2‚ 3 Market
Premium Marketing
SWOT analysis of the Glaxosmithkline. Glaxosmithkline is‚ after Pfizer Inc‚ the largest pharmaceutical company in the world. It was formed in 2000 as the result of a merger between two large companies GlaxoWellcome and SmithKlineBeecham. The company operates primarily in 117 countries‚ their products are currently manufactured in 37 and are sold in over 140 countries. It is headquartered in Brentford‚ England and employs about 110‚000 people with sales of Ł22.7bn. Their strategies for the future
Premium
What are the implications of personal genomes for drug discovery and development ? In the past decade‚ increasing amounts of dollars have been spent on drug development yet the amount of new drugs entering the market per year remains the same. Furthermore with 200 billion dollars of patents expiring in the past four years (Witty‚ 2010)‚ innovative pharmaceutical companies will need to look at new approaches to discover drugs. With the human genome being sequenced in 2003‚ a new field of science
Premium Pharmacology Genetics Genome
April 2013 McClellan GlaxoSmithKline: Ethics and Clinical Thinking GlaxoSmithKline (GSK) is known around the world for many of its home health products and a good number of the prescription drugs that are in our medicine cabinets. GSK is a global healthcare company. They focus on the discovery‚ development‚ manufacturing‚ and marketing of pharmaceutical and consumer health-related products. A brief history of the company‚ according to the Marketline report GlaxoSmithKline: Through Mergers and
Premium